CRANDELL KEITH

CIK 00012190395 companiesCHICAGO, IL

SEC Profile

Transactions

Companies

Filings

CIK

0001219039

Recent Transactions

50 trades

Sale
Trubion Pharmaceuticals, Inc
Common Stock
2010-10-28−14,503→ 0 total
Sale
Trubion Pharmaceuticals, Inc
Common Stock
2010-10-28−2,209,741→ 0 total
Sale
Trubion Pharmaceuticals, Inc
Common Stock
2010-10-28−14,503→ 0 total
Sale
Trubion Pharmaceuticals, Inc
Common Stock
2010-10-28−2,209,741→ 0 total
Sale
Trubion Pharmaceuticals, Inc
Common Stock
2010-10-28−14,503→ 0 total
Sale
Trubion Pharmaceuticals, Inc
Common Stock
2010-10-28−132,802→ 0 total
Sale
Trubion Pharmaceuticals, Inc
Common Stock
2010-10-28−2,209,741→ 0 total
Sale
Trubion Pharmaceuticals, Inc
Common Stock
2010-10-28−2,209,741→ 0 total
Sale
Trubion Pharmaceuticals, Inc
Common Stock
2010-10-28−14,503→ 0 total
Sale
Trubion Pharmaceuticals, Inc
Common Stock
2010-10-28−14,503→ 0 total
Sale
Trubion Pharmaceuticals, Inc
Common Stock
2010-10-28−132,802→ 0 total
Sale
Trubion Pharmaceuticals, Inc
Common Stock
2010-10-28−132,802→ 0 total
Sale
Trubion Pharmaceuticals, Inc
Common Stock
2010-10-28−14,503→ 0 total
Sale
Trubion Pharmaceuticals, Inc
Common Stock
2010-10-28−2,209,741→ 0 total
Sale
Trubion Pharmaceuticals, Inc
Common Stock
2010-10-28−14,503→ 0 total
Sale
Trubion Pharmaceuticals, Inc
Common Stock
2010-10-28−132,802→ 0 total
Sale
Trubion Pharmaceuticals, Inc
Common Stock
2010-10-28−2,209,741→ 0 total
Sale
Trubion Pharmaceuticals, Inc
Common Stock
2010-10-28−14,503→ 0 total
Sale
Trubion Pharmaceuticals, Inc
Common Stock
2010-10-28−2,209,741→ 0 total
Sale
Trubion Pharmaceuticals, Inc
Common Stock
2010-10-28−132,802→ 0 total
Sale
Trubion Pharmaceuticals, Inc
Common Stock
2010-10-28−2,209,741→ 0 total
Sale
Trubion Pharmaceuticals, Inc
Common Stock
2010-10-28−132,802→ 0 total
Sale
Trubion Pharmaceuticals, Inc
Common Stock
2010-10-28−2,209,741→ 0 total
Sale
Trubion Pharmaceuticals, Inc
Common Stock
2010-10-28−132,802→ 0 total
Sale
Trubion Pharmaceuticals, Inc
Common Stock
2010-10-28−14,503→ 0 total
Sale
Trubion Pharmaceuticals, Inc
Common Stock
2010-10-28−132,802→ 0 total
Sale
Trubion Pharmaceuticals, Inc
Common Stock
2010-10-28−2,209,741→ 0 total
Sale
Trubion Pharmaceuticals, Inc
Common Stock
2010-10-28−132,802→ 0 total
Sale
Trubion Pharmaceuticals, Inc
Common Stock
2010-10-28−132,802→ 0 total
Sale
Trubion Pharmaceuticals, Inc
Common Stock
2010-10-28−14,503→ 0 total
Conversion
NeurogesX Inc
Series C2 Convertible Preferred Stock
2007-05-07−7,497,552→ 0 total
Conversion
NeurogesX Inc
Series B Convertible Preferred Stock
2007-05-07−30,347→ 0 total
Conversion
NeurogesX Inc
Series C2 Convertible Preferred Stock
2007-05-07−1,876,992→ 0 total
Conversion
NeurogesX Inc
Series A Convertible Preferred Stock
2007-05-07−4,772,668→ 0 total
Conversion
NeurogesX Inc
Series C Convertible Preferred Stock
2007-05-07−56,900→ 0 total
Conversion
NeurogesX Inc
Series B Convertible Preferred Stock
2007-05-07−2,666,667→ 0 total
Conversion
NeurogesX Inc
Common Stock
2007-05-07+11,004→ 11,004 total
Conversion
NeurogesX Inc
Series B Convertible Preferred Stock
2007-05-07−30,347→ 0 total
Conversion
NeurogesX Inc
Series A Convertible Preferred Stock
2007-05-07−27,312→ 0 total
Conversion
NeurogesX Inc
Series A Convertible Preferred Stock
2007-05-07−4,772,668→ 0 total
Conversion
NeurogesX Inc
Common Stock
2007-05-07+458,903→ 458,903 total
Conversion
NeurogesX Inc
Series C Convertible Preferred Stock
2007-05-07−2,339,915→ 0 total
Conversion
NeurogesX Inc
Series B Convertible Preferred Stock
2007-05-07−5,302,986→ 0 total
Conversion
NeurogesX Inc
Series C2 Convertible Preferred Stock
2007-05-07−50,520→ 0 total
Conversion
NeurogesX Inc
Common Stock
2007-05-07+458,903→ 458,903 total
Conversion
NeurogesX Inc
Series C Convertible Preferred Stock
2007-05-07−56,900→ 0 total
Conversion
NeurogesX Inc
Series B Convertible Preferred Stock
2007-05-07−2,666,667→ 0 total
Conversion
NeurogesX Inc
Series C2 Convertible Preferred Stock
2007-05-07−1,876,992→ 0 total
Conversion
NeurogesX Inc
Series C2 Convertible Preferred Stock
2007-05-07−50,520→ 0 total
Conversion
NeurogesX Inc
Series B Convertible Preferred Stock
2007-05-07−30,347→ 0 total

Companies

Recent Filings

4
ARCH VENTURE FUND V LP
Nov 1, 2010

Address

8725 WEST HIGGINS ROAD SUITE 290

CHICAGO, IL, 60631

View on SEC.gov